research and development

Latest Headlines

Latest Headlines

Sanofi slams doors on Genzyme's Cambridge, U.K., outfit

As part of an ongoing restructuring effort, Sanofi ($SNY) is shuttering Genzyme 's Cambridge, U.K., R&D operation by the end of the year.

Ex-AstraZeneca researchers launch new CRO

Big Pharma's bid to shed in-house drug development continues to create turmoil for the thousands of scientists who have lost or will lose their jobs as the industry streamlines. But rather than...